En coup de sabre linear scleroderma with central nervous system involvement in a pediatric patient

Juvenile localized scleroderma (JLS) is a rare chronic inflammatory disease of connective tissue characterized by inflammation and fibrosis of the skin and underlying tissues, in some cases involving the fascia, muscles, bones, and central nervous system. This paper presents a clinical case of a 5-y...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova Jg. 125; H. 10. Vyp. 2; S. 120
Hauptverfasser: Kulikova, S L, Semashko, M D, Levshuk, O N, Siz, M A, Antonenko, D A
Format: Journal Article
Sprache:Englisch
Russisch
Veröffentlicht: Russia (Federation) 2025
Schlagworte:
ISSN:1997-7298
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Juvenile localized scleroderma (JLS) is a rare chronic inflammatory disease of connective tissue characterized by inflammation and fibrosis of the skin and underlying tissues, in some cases involving the fascia, muscles, bones, and central nervous system. This paper presents a clinical case of a 5-year-old female patient with en coup de sabre linear scleroderma. Three years after the onset of skin manifestations, she developed a stroke-like syndrome with acute left-sided hemiparesis and three focal epileptic seizures in the first week after the hemiparesis occurrence. Magnetic resonance imaging revealed cystic lesions and white matter changes in the right hemisphere of the brain, specifically at the level of the basal ganglia and the frontal lobe. There were no findings in the diffusion weighted imaging (DWI) mode typical for an acute cerebrovascular accident. According to the electroencephalogram, periodic rhythmic deceleration was recorded in the fronto-central-temporal leads of the right hemisphere. Neurological deficit resolved within three weeks. Epileptic seizures were not repeated with levetiracetam therapy at a dose of 20 mg/kg/day during the follow-up period for two years. To date, few cases of patients with localized scleroderma of the face and scalp involving the nervous system have been described. No treatment guidelines have been developed yet. Further research is needed to improve diagnosis and establish the optimal treatment approach.
Bibliographie:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1997-7298
DOI:10.17116/jnevro2025125102120